The Value of the Illness-Death Model for Predicting Outcomes in Patients with Non–Small Cell Lung Cancer
Kum Ju Chae, Hyemi Choi, Won Gi Jeong, Jinheum Kim
Cancer Res Treat. 2022;54(4):996-1004.   Published online 2021 Nov 19     DOI:
Citations to this article as recorded by Crossref logo
Population-based epidemiological projections of rheumatoid arthritis in Germany until 2040
J Wang, S Vordenbäumen, M Schneider, R Brinks
Scandinavian Journal of Rheumatology.2024; : 1.     CrossRef
A population-based projection of psoriatic arthritis in Germany until 2050: analysis of national statutory health insurance data of 65 million German population
Jiancong Wang, Sabrina Tulka, Stephanie Knippschild, Matthias Schneider, Jörg H. W. Distler, Xenofon Baraliakos, Ralph Brinks, Philipp Sewerin
Rheumatology International.2023; 43(11): 2037.     CrossRef
Difference of serum tumor markers in different clinical stages of elderly patients with non-small cell lung cancer and evaluation of diagnostic value
Wen Qin, Ping Wang, CuiMin Ding, Fei Peng
Journal of Medical Biochemistry.2023; 42(4): 607.     CrossRef
Lung cancer mortality and associated predictors: systematic review using 32 scientific research findings
Lijalem Melie Tesfaw, Zelalem G. Dessie, Haile Mekonnen Fenta
Frontiers in Oncology.2023;[Epub]     CrossRef